Why do biopharma’s elites make the annual pilgrimage to Davos?
A who’s-who list of pharma royalty is headed to the Swiss ski resort town of Davos for four days of hobnobbing with politicians, CEOs, and one-percenters from around the globe.
A who’s-who list of biopharma royalty is headed to the Swiss ski resort town of Davos for four days of hobnobbing this week with politicians, CEOs, and one-percenters from around the globe.
There will be big names like Pfizer’s COO Albert Bourla, Novartis’s incoming CEO Vasant Narasimhan, Roche Chairman Christoph Franz, Illumina’s executive chairman Jay Flatley, and Medtronic’s CEO Omar Ishrak. FDA Commissioner Scott Gottlieb will be there, as will the director of the National Institutes of Health, Francis Collins.
